Literature DB >> 18306486

A dumbbell-shaped solitary fibrous tumor of the cervical spinal cord.

Dong Ah Shin1, Se Hoon Kim, Do Heum Yoon, Tai Seung Kim.   

Abstract

A 40-year-old Asian female presented with a 2-month history of right shoulder pain and right triceps weakness. MRI revealed an extramedullary, extradural, dumbbell-shaped spinal cord tumor with C6 to C7 iso- and hyperintensity on T1 and T2 weighted imaging, respectively. Histological examination revealed monomorphous spindle cells with a storiform pattern. Immunohistochemistry was positive for CD34, CD99, and negative for EMA, SMA, and S100; solitary fibrous tumor (SFT) was confirmed.

Entities:  

Mesh:

Year:  2008        PMID: 18306486      PMCID: PMC2615256          DOI: 10.3349/ymj.2008.49.1.167

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


INTRODUCTION

Solitary fibrous tumor (SFT) is a spindle cell neoplasm of assumed mesenchymal fibroblastic origin.1 It was originally described in the thoracic visceral pleura, but has since been reported in extrathoracic sites such as the meninges,2 liver,3 and tunica vaginalis testis.4 Recently, spinal cord and nerve involvement has also been reported.5-8 We report a rare case of SFT mimicking a dumbbell-shaped cervical spinal cord tumor, which had MRI findings different from those in previous reports.6,9,10

CASE REPORT

A 40-year-old Asian female presented with a 2-month history of right shoulder pain and Grade 4 right triceps weakness. Sensory examination revealed no abnormalities. Deep tendon reflexes were hypoactive at the right triceps and normoactive at both knee joints. Evidence of myelopathy was absent. Magnetic resonance imaging (MRI) revealed an extramedullary, extradural, dumbbell-shaped spinal cord tumor at the level of C6-C7 (Fig. 1A, B and C). A computerized tomographic (CT) scan revealed a dumbbell shaped mass and enlarged neural foramen at the level of C6-C7 (Fig. 1D). The tumor measured 5.5cm along its long axis. There was low signal intensity on T2-weighted images, iso-signal intensity on T1-weighted images, and homogenous enhancement by gadolinium. The preoperative impression was schwannoma. Through a midline cervical incision, muscle was bilaterally retracted, and the lower C6 and upper C7 lamina sections and the medial part of the right C6-7 articular joint were removed. The tumor was firmly adhered to the C6-7 neural foramen, and attachments to the right C7 nerve were noted. Excision was performed through a T-shaped incision on the dura and nerve root using a sonic aspirator, with special caution at the nerve root. Gross total resection was accomplished with sparing of the nerves; the tumor was found to have a rubbery consistency and was relatively avascular. The patient's postoperative course was uneventful and her posterior neck pain disappeared. There was no neurological compromise, except mild hypoesthesia of the right middle finger. Histological examination revealed monomorphous spindle cells with a storiform pattern (Fig. 2A), and many areas of perivascular hyalinization. Necrosis and mitoses were absent. Immunohistochemistry was positive for CD34 and CD99 and negative for epithelial membrane antigen (EMA), smooth muscle acting (SMA), and S100 (Fig. 2B). Histological and immunohistochemical findings were consistent with SFT.
Fig. 1

Preoperative magnetic resonance images and computerized tomographic scan showing a dumbbell-shaped, extramedullary, extradural mass with homogenous enhancement at C6-7. A: Sagittal, T2-weighted image showing a hypointense mass behind C6 and C7 vertebral bodies. B: Sagittal, T1-weighted image showing isointense mass. C: Axial, T1-weighted-gadolinium-enhanced image showing a homogenously enhanced mass, located mainly in the extradural space with foraminal extension and partly in the intradural extramedullary space. D: Computerized tomographic scans showing enlarged, right C6-7 neural foramina.

Fig. 2

Pathological findings. A: Hematoxylin and eosin staining showing uniform spindle cells with storiform pattern. The tumor is composed of haphazardly arranged spindle cells with intervening hyaline stroma. Mitosis and necrosis are absent. B: Immunohistochemical staining showing CD34-positive spindle cells.

DISCUSSION

A solitary fibrous tumor is a spindle cell tumor that was first described in the thoracic visceral pleura, but also found in multiple extrathoracic sites, including the meninges,2 liver,3 and tunica vaginalis testis.4 SFT may originate from a unique, perivascular multipotent mesenchyme that shares a lineage with pericytes, fibroblasts, and infrequently, endothelium.1 Consequently, morphological features of SFT may be varied with constituent cells that are predominantly undifferentiated, pericytic, or fibroblastic in nature.1 It has recently been reported that SFT involves both intra- and extramedullary portions of the spinal cord.5-8 Therefore, SFT arising in the spinal cord should be differentiated from schwannoma, meningioma, hemangiopericytoma, and hemangioblastoma.5-9 Clinical and radiological differentiation are not possible. Usual MRI findings included hypointensity on T1- and T2 weighted imaging, reflecting fibrous tissue;6,9,10 however, in our case, isointensity on T1 and hypointensity on T2-weighted imaging were noted. Hemangioblastoma could be ruled out by intraoperative findings.9 Although morphological features are helpful, such as alternating Antoni A and Antoni B areas in schwannoma and cellular whorls and psammoma bodies in meningioma, immunohistochemical findings are essential.7 Schwannomas are invariably S-100 protein positive and meningiomas are epithelial membrane antigen positive, whereas both antibodies are absent in SFT. In addition, SFT is characteristically positive for CD34, bcl-2, and vimentin, but negative for GFAP, neuron specific enolase, and cytokeratin.9 Hemangiopericytoma is CD34 positive in 50%, but dense collagen bands are usually absent.7 Because local recurrence and malignant transformation have been reported, long-term follow up is mandatory.1,2,11,12 Radiation therapy for remnant SFT is not recommended.6 In our case, gross total resection was accomplished, and there was no evidence of mitoses and necrosis; yearly follow-up was scheduled. At 8 months postoperatively, there was no evidence of tumor recurrence. In our case, the tumor was exposed and removed with resection of the medial right C6-7 articular joint half; however, complete removal of a unilateral articular joint may be necessary for large dumbbell-shaped tumors of the cervical spinal cord. In such cases, posterior cervical fusion may be needed to prevent iatrogenic cervical kyphosis and neck pain.13 In conclusion, SFT should be included in the differential diagnoses of spinal cord tumors, especially those that show spindle cell lesions. Most importantly, long term follow-up is necessary due to clinical uncertainty.
  12 in total

1.  Solitary fibrous tumor of the spinal cord.

Authors:  S R Alston; P C Francel; J A Jane
Journal:  Am J Surg Pathol       Date:  1997-04       Impact factor: 6.394

2.  Solitary fibrous tumor of the spinal cord: case report and review of the literature.

Authors:  Mitsuhiro Kawamura; Kazutaka Izawa; Noboru Hosono; Hiroshi Hirano
Journal:  Neurosurgery       Date:  2004-08       Impact factor: 4.654

3.  Cervical intra-/extramedullary solitary fibrous tumour.

Authors:  B Ogungbo; S Prakash; G Kulkarni; N Bradey; S M Marks; D Scoones
Journal:  Br J Neurosurg       Date:  2005-06       Impact factor: 1.596

4.  Localized fibrous tumor (localized fibrous mesothelioma) of the liver.

Authors:  K Kottke-Marchant; W R Hart; T Broughan
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

5.  Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma. A clinicopathologic and immunohistochemical study.

Authors:  S S Carneiro; B W Scheithauer; A G Nascimento; T Hirose; D H Davis
Journal:  Am J Clin Pathol       Date:  1996-08       Impact factor: 2.493

6.  Solitary fibrous tumour of the spinal cord.

Authors:  J P Mordani; I U Haq; J Singh
Journal:  Neuroradiology       Date:  2000-09       Impact factor: 2.804

Review 7.  Solitary fibrous tumor of the spinal cord: a clinicopathologic study of two cases.

Authors:  Stefano Pizzolitto; Giovanni Falconieri; Giovanna Demaglio
Journal:  Ann Diagn Pathol       Date:  2004-10       Impact factor: 2.090

8.  Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites.

Authors:  C A Hanau; M Miettinen
Journal:  Hum Pathol       Date:  1995-04       Impact factor: 3.466

9.  Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors.

Authors:  A V Vallat-Decouvelaere; S M Dry; C D Fletcher
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

10.  Solitary fibrous tumor of the spinal nerve rootlet: report of a case mimicking schwannoma.

Authors:  Simonetta Piana; Innocenza Putrino; Alberto Cavazza; Evandro Nigrisoli
Journal:  Arch Pathol Lab Med       Date:  2004-03       Impact factor: 5.534

View more
  4 in total

1.  Solitary fibrous tumor of the thoracic spine.

Authors:  Rafael Cincu; Ruben Rodriguez; Ana Perez; Trinidad Blanco; Inaki Arrotegui; Carlos Barcia
Journal:  J Neurosci Rural Pract       Date:  2010-07

2.  Recurrence of solitary fibrous tumor of the cervical spinal cord.

Authors:  Kazuyoshi Kobayashi; Shiro Imagama; Zenya Ito; Kei Ando; Junichi Ukai; Akio Muramoto; Ryuichi Shinjo; Tomohiro Matsumoto; Hiroaki Nakashima; Yukihiro Matsuyama; Naoki Ishiguro
Journal:  Nagoya J Med Sci       Date:  2014-02       Impact factor: 1.131

3.  Dumbbell-Shaped Extramedullary Hemangioblastoma of the Thoracic Spine as a Diagnostic Dilemma of Solitary Fibrous Tumor.

Authors:  Senai Goitom Sereke; Felix Bongomin; Geraldine Owor
Journal:  Int Med Case Rep J       Date:  2021-02-12

4.  Solitary fibrous tumor of filum terminale.

Authors:  Yanping Wu; Biao Huang; Changhong Liang
Journal:  Acta Radiol Short Rep       Date:  2012-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.